Fabrazyme

Indicated For

Fabry disease

About This Medication

# CareConnect Copay Assistance Program Guide: Getting Fabrazyme at Low Cost ## What Is This Program? The CareConnect Copay Assistance Program helps eligible patients afford Fabrazyme (agalsidase beta), a critical enzyme replacement therapy for Fabry disease. Sanofi, the manufacturer, created this program to reduce your out-of-pocket costs, including copays, coinsurance, and deductibles. ## Who Can Apply? You may qualify if you: - Have been prescribed Fabrazyme by your doctor - Have active health insurance (private, employer-sponsored, or Medicare) - Meet the program's income limits - Are a U.S. resident **Income Limits:** The program's income eligibility thresholds vary by household size and change annually. Contact the program directly or visit the website to confirm current limits for your situation, as they are adjusted yearly based on federal poverty guidelines. ## Insurance Coverage Requirements This program is **designed for insured patients only**. You must have: - Active prescription drug coverage through a private insurer, employer plan, or Medicare Part D - Out-of-pocket costs (copays, coinsurance, or deductibles) that you're responsible for paying If you're uninsured or underinsured, ask your doctor's office or Sanofi about alternative patient assistance options. ## What Documents Do You Need? To apply, gather: 1. **Proof of income** – Recent tax return, W-2, pay stub, or benefit statement 2. **Insurance information** – Copy of your insurance card 3. **Valid prescription** – From your treating physician 4. **Identification** – Government-issued ID Have these ready before starting your application to speed up the process. ## How to Apply: 4 Easy Steps **Step 1: Access the Program** Visit https://pro.campus.sanofi/us/products/fabrazyme/finance-and-support or ask your doctor's office to help you apply. **Step 2: Complete the Application** You can apply through multiple channels—online, by mail, or with help from your healthcare provider's office. Choose whichever is most convenient. **Step 3: Submit Required Documents** Provide proof of income and your prescription. Keep copies for your records. **Step 4: Receive Your Assistance** Once approved, you'll receive information on how to access your copay card or assistance benefits at the pharmacy. ## What to Expect: Timeline - **Application review:** Typically 5–10 business days - **Approval notification:** You'll be contacted by phone, email, or mail - **Using your benefit:** Start using assistance at your next pharmacy fill **Important:** Reauthorization is **not required** once you're approved. Your assistance continues as long as you remain eligible and your prescription is active. ## Key Program Features **Copay Card Available:** The program includes a savings card that can help reduce your copay to as low as $0 per fill, depending on your plan and income level. **No Ongoing Paperwork:** After initial approval, you don't need to reapply or provide updated income documents annually (unless the program requires it for renewal). **Works With Your Insurance:** This assistance is designed to work *with* your insurance, not replace it. ## Biosimilar Alternatives If Fabrazyme becomes unaffordable or inaccessible, ask your doctor about these alternatives for Fabry disease: - **Elfabrio** (pegunigalsidase alfa) – Another enzyme replacement option - **Galafold** (migalastat) – An oral medication for specific Fabry disease mutations These alternatives may have their own patient assistance programs. ## Need Help? Contact Sanofi's patient support team through the program website at https://pro.campus.sanofi/us/products/fabrazyme/finance-and-support. Your doctor's office can also help navigate the application process and answer questions about your eligibility. ## Important Reminders - Income limits are **not fixed**—verify current thresholds before applying - This program requires **active insurance** - Keep your prescription current to maintain eligibility - If denied, ask why and explore other assistance options Fabry disease treatment shouldn't be delayed by cost. Apply today to start saving on Fabrazyme.

Program information last verified: March 25, 2026